## **Core Concept**
The acellular pertussis vaccine is designed to protect against pertussis (whooping cough) with a reduced risk of side effects compared to the whole-cell pertussis vaccine. It contains specific components of the *Bordetella pertussis* bacteria rather than the entire killed bacteria.

## **Why the Correct Answer is Right**
The correct answer, **D. PT, FHA, PRN, FIM**, lists the common components of the acellular pertussis vaccine. These include:
- **PT (Pertactin)**: Pertussis toxin, which is inactivated to prevent disease but still stimulate an immune response.
- **FHA (Filamentous Hemagglutinin)**: A surface protein of *Bordetella pertussis*.
- **PRN (Pertactin)**: A protein that helps the bacteria adhere to host cells.
- **FIM (Fimbriae types 2 and 3)**: Structures that help the bacteria adhere to the respiratory tract.

These components work together to induce immunity against *Bordetella pertussis* with fewer side effects.

## **Why Each Wrong Option is Incorrect**
- **Option A**: This option is incomplete and does not accurately represent the standard components of the acellular pertussis vaccine.
- **Option B**: Similarly, this option lacks the comprehensive list of components found in the acellular pertussis vaccine.
- **Option C**: This option also does not accurately list the components of the acellular pertussis vaccine.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that acellular pertussis vaccines are used to reduce the risk of adverse reactions associated with whole-cell pertussis vaccines, particularly in developed countries. The typical acellular pertussis vaccine components include PT, FHA, PRN, and sometimes FIM.

## **Correct Answer: D. PT, FHA, PRN, FIM**